Page last updated: 2024-09-03

2-chloro-n(6)cyclopentyladenosine and levodopa

2-chloro-n(6)cyclopentyladenosine has been researched along with levodopa in 1 studies

Compound Research Comparison

Studies
(2-chloro-n(6)cyclopentyladenosine)
Trials
(2-chloro-n(6)cyclopentyladenosine)
Recent Studies (post-2010)
(2-chloro-n(6)cyclopentyladenosine)
Studies
(levodopa)
Trials
(levodopa)
Recent Studies (post-2010) (levodopa)
25204317,7741,9004,946

Protein Interaction Comparison

ProteinTaxonomy2-chloro-n(6)cyclopentyladenosine (IC50)levodopa (IC50)
integrase, partialHuman immunodeficiency virus 10.5939
lens epithelium-derived growth factor p75Homo sapiens (human)0.5939
Epidermal growth factor receptorHomo sapiens (human)2.88
Tyrosine-protein kinase LckHomo sapiens (human)3.729
Tyrosine-protein kinase FynHomo sapiens (human)2.146
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)2.258

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cristalli, G; Morelli, M; Pinna, A; Volpini, R1

Other Studies

1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and levodopa

ArticleYear
New adenosine A2A receptor antagonists: actions on Parkinson's disease models.
    European journal of pharmacology, 2005, Apr-11, Volume: 512, Issue:2-3

    Topics: Adenine; Adenosine; Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Behavior, Animal; Binding, Competitive; Catalepsy; CHO Cells; Cricetinae; Cricetulus; Disease Models, Animal; Drug Synergism; Levodopa; Male; Molecular Structure; Parkinson Disease; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Tritium

2005